Abstract CT193: Tepotinib + gefitinib vs chemotherapy inMET-amplified EGFR-mutant non-small cell lung cancer (NSCLC): Predefined subgroup analysis of a Phase Ib/II study
Clinical Trials(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Clinical Trials(2019)